不动杆菌感染
- 网络acinetobacter infection
-
结果显示:不动杆菌感染的发病率较前增高,占同期肺心病下呼吸道感染的首位(28.57%,30/105例)。
Results showed that morbidity of Acinetobacter infection was higher than before , it was 28 . 57 % among the total infections in the same period .
-
不动杆菌感染及其耐药谱研究
The study on acinetobacter infection and drug resistant spectrum
-
亚胺培南、多黏菌素E是治疗鲍氏不动杆菌感染最有效的抗生素。
Imipenem and polymyxin E are the most effective antibiotics for Acinetobacter baumannii .
-
ICU下呼吸道鲍氏不动杆菌感染耐药性分析
Drug Resistance Analysis for Lower Respiratory Tract Infections of Acinetobacter baumannii in ICU
-
鲍曼不动杆菌感染以重症监护病房(ICU)病房分布最多,其次是神经外科病房;
Acinetobacter baumanii was mainly distributed in ICU wards , then was neurosurgery wards .
-
结论IMP是广州地区治疗不动杆菌感染的最有效的抗生素。
Conclusions IMP is the valid classical antibiotics to Acinetobacter baumannii .
-
方法对鲍曼不动杆菌感染的71例ICU病人进行前瞻性观察,分析泰能和氨苄西林/舒巴坦治疗鲍曼不动杆菌感染病人的临床效果和费用消耗。
Methods A prospective investigation was performed on 71 ICU A. baumannii infection patients treated with imipenem cilastatin and ampicillin sulbactam . The treatment outcomes and antibiotic related costs were also analyzed .
-
下呼吸道不动杆菌感染的临床特征及耐药分析
Clinical Lower Respiratory Tract Infection by Acinetobacter and Their Drug-Resistance Analysis
-
100例不动杆菌感染及药敏结果分析
Immobility Bacilli Infection and Medicine Quick Result Analysis in 100 Patients
-
天津市区慢性支气管炎急性发作患者不动杆菌感染的耐药性分析
Analysis on antibiotic resistance of Acinetobacter from AECB patients in Tianjin
-
结论治疗鲍氏不动杆菌感染必须依据药敏结果合理使用抗生素。
Conclusion Reasonable use of antibiotics based on susceptibility test is needed .
-
82株鲍曼不动杆菌感染特征及耐药性分析
Analysis of infection distribution and drug resistance of Acinetobacter baumannii
-
泰能和氨苄西林/舒巴坦治疗鲍曼不动杆菌感染的临床研究
A clinical study of A. baumannii infection patients treated with imipenem-cilastatin and ampicillin-sulbactam
-
鲍氏不动杆菌感染分布及耐药性动态变迁
Distribution of Acinetobacter baumannii in Nosocomial Infection and Dynamic Changes in Antimicrobial Resistance
-
ICU106株鲍氏不动杆菌感染特点及预防控制
Infection Characteristic , Prevention and Control of 106 Acinetobacter baumannii Strains in ICU
-
儿童鲍氏不动杆菌感染分析及医院感染控制
Acinetobacter baumannii Infection in Children and Hospital Infection Control
-
下呼吸道不动杆菌感染36例临床分析
Clinical analysis of 36 cases of lower respiratory tract infection induced by Acinetobacter
-
不动杆菌感染及耐药性的研究
Study on infection and resistance of acinetobacter calcoaceticus
-
目的了解临床鲍曼不动杆菌感染分布及耐药情况。
Objective To investigated the clinical infections distribution of Acinetobacter baumanii and its drug resistance .
-
不动杆菌感染的药敏分析
Drug Sensitivity Analysis of Amotile Bacilli Infection
-
不动杆菌感染的临床分布特征
Clinical Distribution Characteristic of Acinetobacter Infection
-
外膜蛋白检测与质粒分析对比研究在医院内不动杆菌感染中的应用
Application of Comparative Studies of Outer Membrane Protein and Plasmid Analysis in Nosocomial Infections due to Acinetobacter
-
目前关于鲍曼不动杆菌感染与中医证候相关性的研究资料仍较缺乏,治疗手段相对也较单一。
Acinetobacter Infection and TCM syndrome information was still a lack of treatment is relatively more single .
-
本专案旨在降低加护中心鲍氏不动杆菌感染密度。
The purpose of this project was to reduce the infection density of Acinetobacter Bauniannii in an ICU .
-
目的:研究鲍曼不动杆菌感染情况及对常见抗生素的敏感性。
Objective : To study the infection caused by Acinetobacter baumannii and its sensitivity to the common antibiotics .
-
2001年以鲍曼不动杆菌感染占首位,2002年以真菌感染占首位,2003和2004年以铜绿假单胞菌感染占首位。
The most common lung infection in 2001,2002 and 2003-2004 was caused by Acinetobacter baumannii , fungi and Pseudomonas aeruginosa respectively .
-
重症监护病房鲍氏不动杆菌感染暴发的监控重症感染病原菌的临床分布及药敏分析
Surveillance of Acinetobacter baumannii Outbreak in ICU The analysis on the distribution and antibiotics sensitivities of pathogenic bacteria isolated from serious infection
-
目的了解鲍曼不动杆菌感染分布情况及对20种抗生素耐药性分析。
Objective To understand the distribution of Acinetobacter baumannii infection in local district and make an analysis for its resistance to 20 antibiotics .
-
随着广谱抗菌药物的广泛应用,多重耐药不动杆菌感染日趋增多,给临床抗感染治疗带来了很大的困难。
Broad-spectrum antibiotics having been used widely in hospital , more and more multiple drug-resistant acinetobacter has emerged , which is very difficult to control .
-
结论综合应用隔离、增强病人抵抗力以及局部联用抗生素等措施可以控制烧伤病房多重耐药鲍曼不动杆菌感染。
Conclusion The treatment of isolation and promoted patients resistance , combined with antimicrobial therapy , may control multi-drug resistant Acinetobacter baumannii infections in burn ward .